Physician profile
Jeremy Michael Crow
NPI 1275790073
$966.35
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $126 · 2021: $161 · 2022: $140 · 2023: $290 · 2024: $64.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.94 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $517.36 | 2020-2024 | Itero Element 5d Plus, Invisalign Go, Invisalign |
| Dentsply Sirona INC | $89.35 | 2019-2023 | Tph Spectra Universal Composite Restorative Low Viscosity, Astra Tech Implant System, Palodent Plus Ez Coat Sectional Matrix System |
| Biohorizons Implant Systems INC. | $86.69 | 2021-2024 | Biohorizons |
| Zimmer Biomet Holdings, INC. | $86.67 | 2019 | |
| Kerr Corporation | $63.91 | 2022 | |
| Benco Dental Supply Co. | $47.00 | 2019 | |
| Kulzer, LLC | $26.26 | 2020-2023 | |
| Tulsa Dental Products LLC | $24.26 | 2019 | |
| Kettenbach LP | $15.28 | 2022 | |
| Voco America INC. | $9.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Crow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.